Investors

2024 Q1 Results

Recent Releases

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024

GAITHERSBURG, Md. , May 10, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2024 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 23, 2024 at 9:00 am eastern time.

Emergent BioSolutions Reports First Quarter 2024 Financial Results

First Quarter 2024 Total Revenues of $300.4 million , above the prior guidance range First Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 million Updates FY 2024 guidance GAITHERSBURG, Md. , May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc.

Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position

Proactive changes aim to ensure long-term sustainability and growth, optimize operations, streamline processes, and allocate resources more efficiently Reorganization will align with evolving business goals, strategic priorities and new operational plan Overall efforts expected to deliver annual

Recent Events

05/23/24 05/23/24 9:00 AM EDT Thursday, May 23, 2024 9:00 AM EDT

05/01/24 05/01/24 5:00 PM EDT Wednesday, May 1, 2024 5:00 PM EDT

Woman in Lab

Email Alerts Subscription

Receive email alerts whenever Emergent posts new information.

Sign Up
2023 Annual Report

2023 Annual Report

2024 Proxy Statement

2024 Proxy Statement

ESG Report

2023 ESG Report

IR Contact

Rich Lindahl
Executive Vice President, Chief Financial Officer
Emergent BioSolutions Inc.
Phone: (240) 631-3360
lindahlr@ebsi.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
Toll Free: 877-830-4936
International: 720-378-5591
Website: shareholder.broadridge.com

X